VR headsets may replace painkillers during leg surgery

NCT ID NCT07181434

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether wearing a virtual reality headset with calming scenes and hypnotic speech can lower pain and anxiety during minimally invasive leg artery surgery done under local anesthesia. About 90 adults with peripheral artery disease will take part. The main goal is to see if VR reduces the worst pain felt during the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

virtual reality headset with hypnotic speech

What this could lead to

If it works, this could offer a drug-free way to manage pain and anxiety during certain surgeries, reducing the need for opioids.

What could go wrong

This is a small, early-stage study with only 90 people. The effect may be small or not work for everyone, and VR headsets may not be comfortable for all patients during surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • C.H.U. Poitiers

    Poitiers, 86000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••